A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC)

PHASE3CompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

May 31, 2007

Conditions
AnesthesiaSurgical Procedures, Elective
Interventions
DRUG

Dexmedetomidine

DRUG

Placebo

Trial Locations (27)

10016

NYU School of Medicine, New York

10029

Mount Sinai School of Medicine, New York

13210

SUNY Upstate Medical Center, Syracuse

15261

University of Pittsburgh, Pittsburgh

21117

Crossroads Research Inc., Owings Mills

21122

Chesapeake Research Group, Pasadena

27705

VAMC, Durham

27710

Duke University, Durham

29425

Medical University of South Carolina, Charleston

33136

Jackson Memorial Hospital, Miami

University of Miami, Miami

33143

South Miami Hospital, Miami

35294

University of Alabama, Birmingham

44195

Cleveland Clinic Foundation, Cleveland

48073

William Beaumont Hospital, Royal Oak

53295

VA Medical Center, Milwaukee

65212

University of Missouri Health Care, Columbia

75216

Dallas VA Medical Center, Dallas

75246

Baylor Research Institute, Dallas

76508

Scott & White Memorial Hospital, Temple

77030

MD Anderson Cancer Center, Houston

92354

Loma Linda Medical Center, Loma Linda

21287-0712

Johns Hopkins Hospital, Baltimore

02115

Brigham & Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

43210-1228

The Ohio State University, Columbus

22908-0710

University of Virginia, Charlottesville

All Listed Sponsors
lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00398827 - A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC) | Biotech Hunter | Biotech Hunter